Gluco6 Health
Search documentation... About

Clinical Summary

{You've made the decision|You've decided|You've had enough} — {the side effects of Wegovy aren't worth it|Wegovy's side effects are unbearable|Wegovy is causing more problems than it solves}. {But|However|Yet} {now what?|where do you go from here?|the question becomes: what comes next?} {Quitting wi...

Stopping Wegovy Due to Side Effects — What to Take Instead

Stopping Wegovy Due to Side Effects — What to Take Instead

You’ve had enough — the side effects of Wegovy aren’t worth it. Yet now what? Walking away from GLP-1 therapy empty-handed often leads to losing all your progress. Below you’ll find science-backed supplements and strategies that bridge the gap after stopping Wegovy.


Why Patients Quit Wegovy

The decision to stop Wegovy is usually the result of months of suffering. The most frequent triggers are:

Regardless of why you’re stopping, what matters most is having a plan.


What to Take Instead

Berberine

This plant alkaloid is one of the best-researched natural alternative for people leaving GLP-1 therapy.

Chromium

An often-overlooked mineral, crucial for insulin signaling.

Alpha-Lipoic Acid

This powerful antioxidant is a multifunctional compound that supports both blood sugar and nerve health.

Cinnamon

True cinnamon isn’t just a spice — it has measurable blood sugar effects.

Gluco6 and GlucoTrust

If you want an all-in-one solution these comprehensive formulas bring together berberine, chromium, cinnamon, and other metabolic supporters into one convenient product.


Building Your Post-Wegovy Strategy

Natural alternatives work best as part of a complete strategy. Create a full protocol:


Making the Switch

A gradual transition is safer than a sudden stop. What experts suggest:

  1. Begin supplements 2–4 weeks before your final Wegovy dose
  2. Step down slowly
  3. Keep detailed records during the transition
  4. Be prepared to modify your approach

This overlap strategy helps prevent the metabolic crash that leads to post-medication weight gain.

Consult with a qualified practitioner before making any changes to your medication.

References

Clinical data sourced from FDA prescribing information, published phase III trial results (SUSTAIN, PIONEER, SURPASS, SURMOUNT, STEP programs), and peer-reviewed endocrinology literature. Individual study citations are noted within the article text where applicable.